Ready to Take Charge of Your Health After a Colon Cancer Diagnosis? Start Here.
- Dr. Lena Suhaila
- Apr 7
- 3 min read

Ready to Take Charge of Your Health After a Colon Cancer Diagnosis? Start Here.
If you’re here, chances are you’re not looking to sit back and wait—you’re ready to take action. You’re ready to support your body, mind, and recovery with every tool available. Whether you’ve just been diagnosed with colon cancer or you're already in treatment, this is a moment to shift into a new gear.
Let’s talk about two well-researched, low-risk ways to support your health from the inside out: vitamin D and Turkey Tail mushroom (Coriolus versicolor). These aren’t trends—they’re studied, evidence-backed tools that can support your immune system, improve resilience, and potentially improve outcomes when used alongside conventional care.
Vitamin D: More Than a Supplement—It's a Strategy
Vitamin D is a hormone that plays a significant role in immune regulation, inflammation control, and cell health. And when it comes to colon cancer, the data is compelling.
A large clinical trial (CALGB/SWOG 80702) showed that people with stage III colon cancer and adequate vitamin D levels (≥12 ng/mL) had better overall survival, more extended periods without cancer recurrence, and improved disease-free survival.
Other studies show that supplementing with vitamin D can reduce the risk of adverse outcomes by up to 30%—and the benefits seem even stronger when blood levels are optimized. While 12 ng/mL is considered "not deficient," many health experts recommend shooting for 60- 80 ng/mL for full-body benefits, especially during cancer treatment and recovery.
This is something you can test, track, and adjust—with real impact.
Turkey Tail Mushroom: Powerful Immune Support with Real Results
Coriolus versicolor, or Turkey Tail, is one of the most researched medicinal mushrooms in the world. It's rich in immune-supportive compounds like PSK, and it’s been used for decades in clinical settings in countries like Japan to support patients during cancer treatment.
A 2023 meta-analysis published in Frontiers in Pharmacology found that Coriolus-based natural products were associated with an 18% lower risk of death in cancer patients, including those with colorectal cancer. That’s not a fringe theory—it’s a statistically significant result based on multiple studies.
This isn’t about replacing your treatment plan. It’s about adding targeted, researched support that helps your body do what it’s designed to do: fight, heal, and recover.
Bonus: Mushrooms That Make Their Own Vitamin D
One more reason to pay attention to mushrooms? They’re one of the only natural plant sources of vitamin D. When exposed to UV light (either naturally or through processing), mushrooms synthesize vitamin D2, contributing to your overall levels. Some Turkey Tail products even enhance this effect with UV exposure, giving you immunity and nutrient support.
You're the CEO of Your Health—And This Is Your Next Move
This isn’t about doing everything. It’s about doing the right things—clearly, consistently, and confidently. If you’re ready to:
Take action beyond the basics
Use nutrition and targeted supplements to support your recovery
Make decisions based on research, not trends
Feel informed, supported, and in control of your health journey
Then, you’re already moving in the right direction.
Want to learn how to build a personalized plan to support your whole body during and after treatment? Reach out—let’s talk about what’s possible when you combine innovative science with deep self-care.
Wang QL, Ma C, Yuan C, et al.
Clinical Cancer Research : An Official Journal of the American Association for Cancer Research. 2023;29(14):2621-2630. doi:10.1158/1078-0432.CCR-23-0447.
Vaughan-Shaw PG, Buijs LF, Blackmur JP, et al.
British Journal of Cancer. 2020;123(11):1705-1712. doi:10.1038/s41416-020-01060-8.
Ng K, Nimeiri HS, McCleary NJ, et al.
Jama. 2019;321(14):1370-1379. doi:10.1001/jama.2019.2402.
Fuchs MA, Yuan C, Sato K, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology. 2017;28(6):1359-1367. doi:10.1093/annonc/mdx109
Zhong L, Yan P, Lam WC, Yao L, Bian Z. Frontiers in Pharmacology. 2019;10:703. doi:10.3389/fphar.2019.00703.
Comments